Search hospitals > Maryland > Bethesda
National Cancer Institute (NCI)
Claim this profileBethesda, Maryland 20814
Global Leader in Uterine Tumors
Global Leader in Skin Cancer
Conducts research for Cancer
Conducts research for Lymphoma
Conducts research for Breast Cancer
296 reported clinical trials
11 medical researchers
Summary
National Cancer Institute (NCI) is a medical facility located in Bethesda, Maryland. This center is recognized for care of Uterine Tumors, Skin Cancer, Cancer, Lymphoma, Breast Cancer and other specialties. National Cancer Institute (NCI) is involved with conducting 296 clinical trials across 367 conditions. There are 11 research doctors associated with this hospital, such as A P. Chen, Nirali N. Shah, John Glod, MD, and Deborah Citrin, MD.Area of expertise
1Uterine Tumors
Global LeaderStage IV
Stage III
PD-L1 positive
2Skin Cancer
Global LeaderStage IV
Stage III
FH positive
Top PIs
A P. ChenNational Institutes of Health Clinical Center2 years of reported clinical research
Expert in Cancer
Expert in Uterine Tumors
25 reported clinical trials
68 drugs studied
Nirali N. ShahNational Institutes of Health, Clinical Center8 years of reported clinical research
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Lymphoblastic Leukemia
12 reported clinical trials
16 drugs studied
John Glod, MDNational Cancer Institute Pediatric Oncology Branch9 years of reported clinical research
Studies Cerebral Gliomas
Studies Soft Tissue Sarcoma
10 reported clinical trials
13 drugs studied
Deborah Citrin, MDNational Cancer Institute2 years of reported clinical research
Studies Prostate Cancer
Studies Benign Prostatic Hyperplasia
6 reported clinical trials
10 drugs studied
Clinical Trials running at National Cancer Institute (NCI)
Skin Cancer
Bladder Cancer
Small Cell Lung Cancer
Kidney Cancer
Hairy Cell Leukemia
Neurofibromatosis
Melanoma
Uterine Tumors
Peripheral Nerve Sheath Tumor
Squamous Cell Carcinoma
Lifileucel + Pembrolizumab
for Melanoma
This is a Phase 3, multicenter, open-label, randomized, parallel group, treatment study to assess the efficacy and safety of lifileucel in combination with pembrolizumab compared with pembrolizumab alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who subsequently have a blinded independent central review- verified confirmed progressive disease (PD) will be offered lifileucel monotherapy in an optional crossover period.
Recruiting2 awards Phase 37 criteria
Olaparib
for Bladder Cancer
This trial studies how well olaparib works in patients with advanced bladder and other genitourinary cancers that have DNA-repair defects. Olaparib is a drug that stops cancer cells from fixing their damaged DNA, which can help to stop the cancer from growing. The trial targets patients whose cancers have spread and are not responsive to standard treatments.
Recruiting1 award Phase 220 criteria
Tazemetostat + Topotecan + Pembrolizumab
for Small Cell Lung Cancer
This phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tazemetostat in combination with topotecan and pembrolizumab may shrink or stabilize recurrent small cell lung cancer.
Recruiting1 award Phase 119 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at National Cancer Institute (NCI)?
National Cancer Institute (NCI) is a medical facility located in Bethesda, Maryland. This center is recognized for care of Uterine Tumors, Skin Cancer, Cancer, Lymphoma, Breast Cancer and other specialties. National Cancer Institute (NCI) is involved with conducting 296 clinical trials across 367 conditions. There are 11 research doctors associated with this hospital, such as A P. Chen, Nirali N. Shah, John Glod, MD, and Deborah Citrin, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.